Ms Fiumenero joined Vitae in January 2006 as senior vice president of finance and administration. Prior to joining Vitae Pharmaceuticals, Ms Fiumenero has spent 13 years at Bristol-Myers Squibb where she held a held a number of finance positions of increasing responsibility spanning US commercial operations, mergers and acquisitions and manufacturing.
Jeffrey Hatfield, CEO of Vitae, said: “Tina’s intense focus on building shareholder value and driving capital efficiency have helped put Vitae in a strong financial position. As Vitae continues to advance its growing pipeline, Tina’s impressive strategic and operational skills will help ensure Vitae’s long-term ability to succeed.”